Cannaweek - Cannabis Intelligence

UK Guidelines Adverse Effect on Medicinal Cannabis

Episode Summary

A conversation with Nick Pateras, Managing Director for Europe at Materia Ventures and CKO of New Frontier Data, John Kagia. They discuss how a court challenge to the NHS's stance on medicinal Cannabis could fundamentally change the EU's market landscape.

Episode Notes

Host Heather Wicklein talks with Nick Pateras, Managing Director for Europe at Materia Ventures and CKO of New Frontier Data, John Kagia. They discuss recent challenges to the NHS's interpretation of medical Cannabis' efficacy. They explore how the National Institute for Health and Care Excellence (NICE)  failure to recommend Cannabis as a viable treatment has led to nearly no prescriptions being offered by the UK's doctors. The also discuss the recent push for adult-use legalization amid budgeting shortfalls in the UK's government. 

Contact: Cannaweek@newfrontierdata.com 

Instagram

Twitter

www.newfrontierdata.com